Moderna Stock Has 33% Upside, According to 1 Wall Street Analyst
Moderna(MRNA) The Motley Fool·2024-02-28 11:38Regarding Moderna (MRNA 2.32%) stock, RBC Capital analyst Luca Issi is bullish. Per his price target of $125 that he reiterated on Feb. 23, the biotech's shares could rise by 30% to reach $125. There are a few upcoming developments that could stimulate the stock to grow in the way that Issi predicts.Management expects its respiratory syncytial virus (RSV) vaccine will pick up a few regulatory approvals in the first half of the year, paving the way for worldwide launches, with sales revenue to follow. Separa ...